Current Management Strategies of Chronic Kidney Disease in Resource-Limited Countries

References

• Schoolwerth AC, Engelgau MM, Hostetter TH, et al. Chronic kidney disease: a public health problem that needs a public health action plan. Prev Chronic Dis. 2006;3(2):A57.16539798
   PubMedGoogle Scholar
• Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: global dimension and perspectives. Lancet. 2013;382(9888):260–272. doi:10.1016/S0140-6736(13)60687-X23727169
   PubMed Web of Science ®Google Scholar
• Bikbov B, Purcell CA, Levey AS. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–733. doi:10.1016/S0140-6736(20)30045-332061315
   PubMed Web of Science ®Google Scholar
• Foreman KJ, Marquez N, Dolgert A, et al. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. 2018;392(10159):2052–2090. doi:10.1016/S0140-6736(18)31694-530340847
   PubMed Web of Science ®Google Scholar
• Xie Y, Bowe B, Mokdad AH, et al. Analysis of the Global Burden of Disease study highlights the global, regional, and national trends of chronic kidney disease epidemiology from 1990 to 2016. Kidney Int. 2018;94(3):567–581. doi:10.1016/j.kint.2018.04.01130078514
   PubMed Web of Science ®Google Scholar
• Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease - a systematic review and meta-analysis. PLoS One. 2016;11(7):e0158765. doi:10.1371/journal.pone.015876527383068
   PubMed Web of Science ®Google Scholar
• Bello AKLA, Tonelli M, Okpechi IG, et al. Global Kidney Health Atlas: a report by the International Society of Nephrology on the current state of organization and structures for kidney care across the globe. Kidney Int Suppl. 2017;7(2):145–153.
   Web of Science ®Google Scholar
• Bello AK, Levin A, Tonelli M, et al. Assessment of global kidney health care status. JAMA. 2017;317(18):1864–1881. doi:10.1001/jama.2017.404628430830
   PubMed Web of Science ®Google Scholar
• Bello AK, Ronksley PE, Tangri N, et al. Quality of chronic kidney disease management in Canadian primary care. JAMA Netw Open. 2019;2(9):e1910704. doi:10.1001/jamanetworkopen.2019.1070431483474
   PubMed Web of Science ®Google Scholar
• Bello AK, Levin A, Lunney M, et al. Status of care for end stage kidney disease in countries and regions worldwide: international cross sectional survey. BMJ. 2019;367:l5873. doi:10.1136/bmj.l587331672760
   PubMed Web of Science ®Google Scholar
• Ashuntantang G, Osafo C, Olowu WA, et al. Outcomes in adults and children with end-stage kidney disease requiring dialysis in sub-Saharan Africa: a systematic review. Lancet Global Health. 2017;5(4):e408–e417. doi:10.1016/S2214-109X(17)30057-828229924
   PubMed Web of Science ®Google Scholar
• Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet. 2015;385(9981):1975–1982. doi:10.1016/S0140-6736(14)61601-925777665
   PubMed Web of Science ®Google Scholar
• WorldBank. World Bank Country and Lending Groups. 2020 Available from: https://datahelpdesk.worldbank.org/knowledgebase/articles/906519-world-bank-country-and-lending-groups.
   Google Scholar
• KDIGO. Kidney Disease: improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int. 2013;3:1–150.
   Web of Science ®Google Scholar
• George C, Mogueo A, Okpechi I, Echouffo-Tcheugui JB, Kengne AP. Chronic kidney disease in low-income to middle-income countries: the case for increased screening. BMJ Glob Health. 2017;2(2):e000256. doi:10.1136/bmjgh-2016-000256
   Web of Science ®Google Scholar
• Wyatt CM, Schwartz GJ, Owino Ong’or W, et al. Estimating kidney function in HIV-infected adults in Kenya: comparison to a direct measure of glomerular filtration rate by iohexol clearance. PLoS One. 2013;8(8):e69601. doi:10.1371/journal.pone.006960123950899
   PubMed Web of Science ®Google Scholar
• Ekrikpo UE, Kengne AP, Bello AK, et al. Chronic kidney disease in the global adult HIV-infected population: a systematic review and meta-analysis. PLoS One. 2018;13(4):e0195443. doi:10.1371/journal.pone.019544329659605
   PubMed Web of Science ®Google Scholar
• Anker N, Scherzer R, Peralta C, Powe N, Banjeree T, Shlipak M. Racial disparities in creatinine-based kidney function estimates among HIV-infected adults. Ethn Dis. 2016;26(2):213–220. doi:10.18865/ed.26.2.21327103772
   PubMed Web of Science ®Google Scholar
• Rule AD. Understanding estimated glomerular filtration rate: implications for identifying chronic kidney disease. Curr Opin Nephrol Hypertens. 2007;16(3):242–249. doi:10.1097/MNH.0b013e328057de8b17420668
   PubMed Web of Science ®Google Scholar
• Senanayake S, Gunawardena N, Palihawadana P, et al. Symptom burden in chronic kidney disease; a population based cross sectional study. BMC Nephrol. 2017;18(1):228. doi:10.1186/s12882-017-0638-y28693434
   PubMed Web of Science ®Google Scholar
• Brown SA, Tyrer FC, Clarke AL, et al. Symptom burden in patients with chronic kidney disease not requiring renal replacement therapy. Clin Kidney J. 2017;10(6):788–796. doi:10.1093/ckj/sfx05729225808
   PubMed Web of Science ®Google Scholar
• Choukem SP, Nchifor PK, Halle MP, et al. Knowledge of physicians on chronic kidney disease and their attitudes towards referral, in two cities of Cameroon: a cross-sectional study. BMC Res Notes. 2016;9:29. doi:10.1186/s13104-016-1845-526781039
   PubMedGoogle Scholar
• Marie Patrice H, Joiven N, Hermine F, Jean Yves B, Folefack François K, Enow Gloria A. Factors associated with late presentation of patients with chronic kidney disease in nephrology consultation in Cameroon-a descriptive cross-sectional study. Ren Fail. 2019;41(1):384–392. doi:10.1080/0886022X.2019.159564431106687
   PubMed Web of Science ®Google Scholar
• Osman MA, Alrukhaimi M, Ashuntantang GE, et al. Global nephrology workforce: gaps and opportunities toward a sustainable kidney care system. Kidney Int. 2018;8(2):52–63. doi:10.1016/j.kisu.2017.10.009
   Web of Science ®Google Scholar
• Htay H, Alrukhaimi M, Ashuntantang GE, et al. Global access of patients with kidney disease to health technologies and medications: findings from the Global Kidney Health Atlas project. Kidney Int Suppl. 2018;8(2):64–73. doi:10.1016/j.kisu.2017.10.010
   Web of Science ®Google Scholar
• WorldBank. Research and development expenditure (% of GDP); 2020 Available from: https://data.worldbank.org/indicator/GB.XPD.RSDV.GD.ZS. Accessed 34, 2020.
   Google Scholar
• Ekrikpo UE, Udo AI, Ikpeme EE, Effa EE. Haemodialysis in an emerging centre in a developing country: a two year review and predictors of mortality. BMC Nephrol. 2011;12:50. doi:10.1186/1471-2369-12-5021962220
   PubMed Web of Science ®Google Scholar
• Ekrikpo UE, Mnika K, Effa EE, et al. Association of genetic polymorphisms of TGF-β1, HMOX1, and APOL1 with CKD in Nigerian patients with and without HIV. Am J Kidney Dis. 2020;76(1):100–108. doi:10.1053/j.ajkd.2020.01.00632354559
   PubMed Web of Science ®Google Scholar
• Ulasi II, Tzur S, Wasser WG, et al. High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from South-Eastern Nigeria. Nephron Clin Pract. 2013;123(1–2):123–128. doi:10.1159/00035322323860441
   PubMedGoogle Scholar
• Ameh OI, Ekrikpo UE, Kengne AP. Preventing CKD in low- and middle-income countries: a call for urgent action. Kidney Int Rep. 2020;5(3):255–262. doi:10.1016/j.ekir.2019.12.01332154447
   PubMed Web of Science ®Google Scholar
• Powe NR, Boulware LE. Population-based screening for CKD. Am J Kidney Dis. 2009;53(3 Suppl 3):S64–70. doi:10.1053/j.ajkd.2008.07.05019231763
   PubMed Web of Science ®Google Scholar
• Mosha NR, Mahande M, Juma A, et al. Prevalence,awareness and factors associated with hypertension in North West Tanzania. Glob Health Action. 2017;10(1):1321279. doi:10.1080/16549716.2017.132127928598724
   PubMed Web of Science ®Google Scholar
• Sarveswaran G, Kulothungan V, Mathur P. Clustering of noncommunicable disease risk factors among adults (18–69 years) in rural population, South-India. Diabetes Metab Syndr. 2020;14(5):1005–1014. doi:10.1016/j.dsx.2020.05.04232623362
   PubMed Web of Science ®Google Scholar
• Singh AK, Farag YM, Mittal BV, et al. Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) study. BMC Nephrol. 2013;14:114. doi:10.1186/1471-2369-14-11423714169
   PubMed Web of Science ®Google Scholar
• Alsuwaida AO, Farag YM, Al Sayyari AA, et al. Epidemiology of chronic kidney disease in the Kingdom of Saudi Arabia (SEEK-Saudi investigators) - a pilot study. Saudi J Kidney Dis Transpl. 2010;21(6):1066–1072.21060175
   PubMedGoogle Scholar
• Obrador GT, García-García G, Villa AR, et al. Prevalence of chronic kidney disease in the Kidney Early Evaluation Program (KEEP) México and comparison with KEEP US. Kidney Int. 2010;77:S2–S8. doi:10.1038/ki.2009.540
   Web of Science ®Google Scholar
• Koshy SM, Garcia-Garcia G, Pamplona JS, et al. Screening for kidney disease in children on World Kidney Day in Jalisco, Mexico. Pediatr Nephrol. 2009;24(6):1219–1225. doi:10.1007/s00467-009-1136-719271247
   PubMed Web of Science ®Google Scholar
• Sumaili EK, Nseka NM, Lepira FB, et al. Screening for proteinuria and chronic kidney disease risk factors in Kinshasa: a world kidney day 2007 study. Nephron Clin Pract. 2008;110(4):c220–c228. doi:10.1159/00016786918974653
   PubMedGoogle Scholar
• Rai PK, Rai P, Bhat RG, Bedi S. Chronic kidney disease among middle-aged and elderly population: a cross-sectional screening in a Hospital Camp in Varanasi, India. Saudi J Kidney Dis Transpl. 2019;30(4):795–802. doi:10.4103/1319-2442.26545431464235
   PubMed Web of Science ®Google Scholar
• Beaney T, Schutte AE, Stergiou GS, et al. May measurement month 2019: the global blood pressure screening campaign of the international society of hypertension. Hypertension. 2020;76(2):333–341. doi:10.1161/HYPERTENSIONAHA.120.1487432419505
   PubMed Web of Science ®Google Scholar
• Okpechi IG, Bello AK, Ameh OI, Swanepoel CR. Integration of care in management of CKD in resource-limited settings. Semin Nephrol. 2017;37(3):260–272. doi:10.1016/j.semnephrol.2017.02.00628532555
   PubMed Web of Science ®Google Scholar
• WHO. Innovative care for chronic conditions: building blocks for action. Global report. Geneva: WHO/NMC/CCH; 2002 Available from: http://www.who.int/chp/knowledge/publications/icccreport/en/. Accessed October 6, 2020.
   Google Scholar
• Oni T, McGrath N, BeLue R, et al. Chronic diseases and multi-morbidity–a conceptual modification to the WHO ICCC model for countries in health transition. BMC Public Health. 2014;14:575. doi:10.1186/1471-2458-14-57524912531
   PubMed Web of Science ®Google Scholar
• Chang W, Chamie G, Mwai D, et al. Implementation and operational research: cost and efficiency of a hybrid mobile multidisease testing approach with high HIV testing coverage in East Africa. J Acquir Immune Defic Syndr. 2016;73(3):e39–e45. doi:10.1097/QAI.000000000000114127741031
   PubMed Web of Science ®Google Scholar
• Jiamjariyapon T, Ingsathit A, Pongpirul K, et al. Effectiveness of integrated care on delaying progression of stage 3–4 chronic kidney disease in rural communities of Thailand (ESCORT study): a cluster randomized controlled trial. BMC Nephrol. 2017;18(1):83. doi:10.1186/s12882-016-0414-428253839
   PubMed Web of Science ®Google Scholar
• Stanifer JW, Von Isenburg M, Chertow GM, Anand S. Chronic kidney disease care models in low- and middle-income countries: a systematic review. BMJ Glob Health. 2018;3(2):e000728. doi:10.1136/bmjgh-2018-000728
   PubMed Web of Science ®Google Scholar
• Okpechi IG. ESKD in sub-Saharan Africa: will governments now listen? Lancet Global Health. 2017;5(4):e373–e374. doi:10.1016/S2214-109X(17)30070-028229925
   PubMed Web of Science ®Google Scholar
• Mills KT, Bundy JD, Kelly TN, et al. Global disparities of hypertension prevalence and control: a systematic analysis of population-based studies from 90 countries. Circulation. 2016;134(6):441–450. doi:10.1161/CIRCULATIONAHA.115.01891227502908
   PubMed Web of Science ®Google Scholar
• Ojji DB, Mayosi B, Francis V, et al. Comparison of dual therapies for lowering blood pressure in Black Africans. N Engl J Med. 2019;380(25):2429–2439. doi:10.1056/NEJMoa190111330883050
   PubMed Web of Science ®Google Scholar
• IDF. IDF diabetes atlas; 2019 Available from: https://www.diabetesatlas.org/en/.
   Google Scholar
• Perkovic V, Jardine MJ, Neal B, et al. Canagliflozin and renal outcomes in type 2 diabetes and nephropathy. N Engl J Med. 2019;380(24):2295–2306. doi:10.1056/NEJMoa181174430990260
   PubMed Web of Science ®Google Scholar
• Jingi AM, Noubiap JJ, Ewane Onana A, et al. Access to diagnostic tests and essential medicines for cardiovascular diseases and diabetes care: cost, availability and affordability in the West Region of Cameroon. PLoS One. 2014;9(11):e111812. doi:10.1371/journal.pone.011181225369455
   PubMed Web of Science ®Google Scholar
• Swanepoel CR, Wearne N, Okpechi IG. Nephrology in Africa—not yet uhuru. Nat Rev Nephrol. 2013;9(10):610–622. doi:10.1038/nrneph.2013.16823958719
   PubMed Web of Science ®Google Scholar
• Floege J, Barbour SJ, Cattran DC, et al. Management and treatment of glomerular diseases (part 1): conclusions from a Kidney Disease: improving global outcomes (KDIGO) controversies conference. Kidney Int. 2019;95(2):268–280. doi:10.1016/j.kint.2018.10.01830665568
   PubMed Web of Science ®Google Scholar
• Wearne N, Swanepoel CR, Boulle A, Duffield MS, Rayner BL. The spectrum of renal histologies seen in HIV with outcomes, prognostic indicators and clinical correlations. Nephrol Dial Transplant. 2012;27(11):4109–4118. doi:10.1093/ndt/gfr70222200584
   PubMed Web of Science ®Google Scholar
• Wearne N, Swanepoel CR, Duffield MS, et al. The effects of add-on corticosteroids on renal outcomes in patients with biopsy proven HIV associated nephropathy: a single centre study from South Africa. BMC Nephrol. 2019;20(1):44. doi:10.1186/s12882-019-1208-230728003
   PubMed Web of Science ®Google Scholar
• Alebie G, Urga B, Worku A. Systematic review on traditional medicinal plants used for the treatment of malaria in Ethiopia: trends and perspectives. Malar J. 2017;16(1):307. doi:10.1186/s12936-017-1953-228764723
   PubMed Web of Science ®Google Scholar
• Tsabang N, Yedjou CG, Tsambang L, et al. Treatment of diabetes and/or hypertension using medicinal plants in Cameroon. Med Aromat Plants (Los Angel). 2015;(Suppl 2).
   Google Scholar
• Luyckx VA, Naicker S. Acute kidney injury associated with the use of traditional medicines. Nat Clin Pract Nephrol. 2008;4(12):664–671. doi:10.1038/ncpneph097018838981
   PubMedGoogle Scholar
• De Broe ME. Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy. Kidney Int. 2012;81(6):513–515. doi:10.1038/ki.2011.42822373701
   PubMed Web of Science ®Google Scholar
• Akande-Sholabi W, Agha PC, Olowookere OO, Adebusoye LA. Evaluation of prescription pattern of analgesic use among ambulatory elderly in South-Western Nigeria. Ann Afr Med. 2020;19(2):131–136. doi:10.4103/aam.aam_57_1932499470
   PubMed Web of Science ®Google Scholar
• KDIGO. Kidney disease improving global outcomes AKIWG. KDIGO clinical practice guidelines for acute kidney injury. Kidney Int Suppl. 2012;2:1–138.
   Web of Science ®Google Scholar
• Ameh OI, Cilliers L, Okpechi IG. A practical approach to the nutritional management of chronic kidney disease patients in Cape Town, South Africa. BMC Nephrol. 2016;17(1):68. doi:10.1186/s12882-016-0297-427391878
   PubMed Web of Science ®Google Scholar
• Correa-Rotter R, Wesseling C, Johnson RJ. CKD of unknown origin in Central America: the case for a Mesoamerican nephropathy. Am J Kidney Dis. 2014;63(3):506–520. doi:10.1053/j.ajkd.2013.10.06224412050
   PubMed Web of Science ®Google Scholar
• Wijkström J, Jayasumana C, Dassanayake R, et al. Morphological and clinical findings in Sri Lankan patients with chronic kidney disease of unknown cause (CKDu): similarities and differences with Mesoamerican Nephropathy. PLoS One. 2018;13(3):e0193056. doi:10.1371/journal.pone.019305629513702
   PubMed Web of Science ®Google Scholar
• Ganguli A. Uddanam nephropathy/regional nephropathy in India: preliminary findings and a plea for further research. Am J Kidney Dis. 2016;68(3):344–348. doi:10.1053/j.ajkd.2016.04.01227209444
   PubMed Web of Science ®Google Scholar
• El Minshawy O. End-stage renal disease in the El-Minia Governorate, upper Egypt: an epidemiological study. Saudi J Kidney Dis Transpl. 2011;22(5):1048–1054.21912050
   PubMedGoogle Scholar
• Johnson RJ, Wesseling C, Newman LS, Ingelfinger JR. Chronic kidney disease of unknown cause in agricultural communities. N Engl J Med. 2019;380(19):1843–1852. doi:10.1056/NEJMra181386931067373
   PubMed Web of Science ®Google Scholar
• Hung SC, Kuo KL, Peng CH, et al. Volume overload correlates with cardiovascular risk factors in patients with chronic kidney disease. Kidney Int. 2014;85(3):703–709. doi:10.1038/ki.2013.33624025647
   PubMed Web of Science ®Google Scholar
• Inker LA, Coresh J, Levey AS, Tonelli M, Muntner P. Estimated GFR, albuminuria, and complications of chronic kidney disease. J Am Soc Nephrol. 2011;22(12):2322–2331. doi:10.1681/ASN.201011118121965377
   PubMed Web of Science ®Google Scholar
• Oziegbe-Ojeh E, Okaka E. Financial implications of anemia management in anaemic chronic kidney disease patients in South-South Nigeria. Ann Biomed Sci. 2017;16(2):151–162.
   Google Scholar
• Fujii H, Joki N. Mineral metabolism and cardiovascular disease in CKD. Clin Exp Nephrol. 2017;21(Suppl S1):53–63. doi:10.1007/s10157-016-1363-828062938
   PubMed Web of Science ®Google Scholar
• Innes A, Rowe PA, Burden RP, Morgan AG. Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant. 1992;7(6):467–471.1320224
   PubMed Web of Science ®Google Scholar
• Ismail N, Neyra R, Hakim R. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant. 1998;13(2):246–250. doi:10.1093/ndt/13.2.2469509429
   PubMed Web of Science ®Google Scholar
• Hayashi T, Kimura T, Yasuda K, et al. Early nephrology referral 6 months before dialysis initiation can reduce early death but does not improve long-term cardiovascular outcome on dialysis. Circ J. 2016;80(4):1008–1016. doi:10.1253/circj.CJ-15-101326876973
   PubMed Web of Science ®Google Scholar
• Winkelmayer WC, Glynn RJ, Levin R, Owen WF, Avorn J. Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001;38(6):1178–1184. doi:10.1053/ajkd.2001.2920711728948
   PubMed Web of Science ®Google Scholar
• Manns B, Hemmelgarn B, Tonelli M, et al. The cost of care for people with chronic kidney disease. Can J Kidney Health Dis. 2019;6:2054358119835521. doi:10.1177/205435811983552131057803
   PubMedGoogle Scholar
• Gelfand SL, Scherer JS, Koncicki HM. Kidney supportive care: core curriculum 2020. Am J Kidney Dis. 2020;75(5):793–806. doi:10.1053/j.ajkd.2019.10.01632173108
   PubMed Web of Science ®Google Scholar
• Nelson RG, Pankratz VS, Ghahate DM, Bobelu J, Faber T, Shah VO. Home-based kidney care, patient activation, and risk factors for CKD progression in Zuni Indians: a randomized, controlled clinical trial. Clin J Am Soc Nephrol. 2018;13(12):1801–1809. doi:10.2215/CJN.0691061830442864
   PubMed Web of Science ®Google Scholar
• Davy C, Bleasel J, Liu H, Tchan M, Ponniah S, Brown A. Effectiveness of chronic care models: opportunities for improving healthcare practice and health outcomes: a systematic review. BMC Health Serv Res. 2015;15:194. doi:10.1186/s12913-015-0854-825958128
   PubMed Web of Science ®Google Scholar
• Si D, Bailie R, Weeramanthri T. Effectiveness of chronic care model-oriented interventions to improve quality of diabetes care: a systematic review. Prim Health Care Res Dev. 2008;9(1):25–40. doi:10.1017/S1463423607000473
   Google Scholar
• Pasricha A, Deinstadt RT, Moher D, Killoran A, Rourke SB, Kendall CE. Chronic care model decision support and clinical information systems interventions for people living with HIV: a systematic review. J Gen Intern Med. 2013;28(1):127–135. doi:10.1007/s11606-012-2145-y22790615
   PubMed Web of Science ®Google Scholar
• Coleman K, Austin BT, Brach C, Wagner EH. Evidence on the Chronic Care Model in the new millennium. Health Aff (Millwood). 2009;28(1):75–85. doi:10.1377/hlthaff.28.1.7519124857
   PubMed Web of Science ®Google Scholar
• Woltmann E, Grogan-Kaylor A, Perron B, Georges H, Kilbourne AM, Bauer MS. Comparative effectiveness of collaborative chronic care models for mental health conditions across primary, specialty, and behavioral health care settings: systematic review and meta-analysis. Am J Psychiatr. 2012;169(8):790–804. doi:10.1176/appi.ajp.2012.1111161622772364
   PubMed Web of Science ®Google Scholar
• Moullec G, Gour-Provencal G, Bacon SL, Campbell TS, Lavoie KL. Efficacy of interventions to improve adherence to inhaled corticosteroids in adult asthmatics: impact of using components of the chronic care model. Respir Med. 2012;106(9):1211–1225. doi:10.1016/j.rmed.2012.06.00122770682
   PubMed Web of Science ®Google Scholar